SCHEMBL3762979

SCHEMBL3762979

CC(OC(=O)OC(C)S(=O)(=O)c1cccc2c(N(C)C)cccc12)S(=O)(=O)c1cccc2c(N(C)C)cccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.54
F2 P00734 3/20 0.50
PRSS1 P07477 3/20 0.50
PRSS2 P07478 3/20 0.50
PRSS3 P35030 3/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
HIF1A Q16665 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
EDNRA P25101 4/20 0.45
PTGS2 P35354 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6046339 0.81 CA2 (0.61) CA2F2PRSS1PRSS2PRSS3
SCHEMBL1268593 0.81 CA2 (0.54) CA2F2PRSS1PRSS2PRSS3
SCHEMBL1105200 0.81 CA2 (0.65) CA2F2PRSS1PRSS2PRSS3
SCHEMBL7558142 0.78 CA2 (0.61) CA2F2PRSS1PRSS2PRSS3
SCHEMBL28337330 0.76 CA2 (0.55) CA2F2PRSS1PRSS2PRSS3
SCHEMBL28046229 0.76 CA2 (0.59) CA2F2PRSS1PRSS2PRSS3
SCHEMBL28751226 0.76 F2 (0.56) CA2F2PRSS1PRSS2PRSS3
SCHEMBL214991 0.75 CA2 (0.57) CA2F2PRSS1PRSS2PRSS3
SCHEMBL133520 0.74 CA2 (0.69) CA2F2PRSS1PRSS2PRSS3
SCHEMBL29941705 0.74 CA2 (0.69) CA2F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754252-B2 Asymmetric cyclization processes using unsaturated nitro compounds NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-06-17 US disclosed
US-20130096338-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-04-18 US disclosed
US-20100298576-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096338-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NQO1, COASY, NOS2 CA2 3725/4885F2 1363/4885PRSS1 4002/4885
US-20100298576-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NQO1, COASY, NOS2 CA2 3725/4885F2 1363/4885PRSS1 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.